We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00401024
Recruitment Status : Completed
First Posted : November 17, 2006
Last Update Posted : July 27, 2010
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)